SBIR/STTR Research Award
Not Available
Award amount
$199,635Program and phase
SBIR · Phase IAward year
2010Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BIOMEDOMICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2010-1
- Topic code
- NCI
Research abstract
The contractor (BioMedomics, Inc.) proposes to develop a nanosensing platform which is a label-free, real-time multiplexed detection of cancer biomarkers with high selectivity and sensitivity using antibody-functionalized, carbon-nanotube field-effect transistor (FFT) sensor and lateral flow immunoassay technologies. The contractor will work with Duke Professor Liu¿s group to develop the technology for cancer biomarker detection by combining novel nanotube array and lateral flow immunoassay technologies. This nanotube array based sensing platform produces high sensitivity for cancer biomarker detection and therefore provides increased specificity in recognizing cancer that would offer clinicians accurate clinical prognosis. The platforms can be used for early detection of initial onset of disease, or be used as post-treatment monitoring to detect recurrence of disease.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis